biotech

5 things to know in life sciences: Week of April 20, 2026

The FDA has advanced a plan to reduce animal testing. This and more in this week’s life sciences update. … READ MORE >

Biotech IPOs begin to pick back up in Q2. This and more in this week’s life sciences update. … READ MORE >

Accelerator program selects early-stage life sciences startups to fuel next-gen innovation. This and more in this week’s update. … READ MORE >

AI is moving from experimentation to operational core in clinical trials. This and more in this week’s life sciences update. … READ MORE >

The FDA launches domestic drug manufacturing precheck program. This and more in this week’s life sciences industry update. … READ MORE >

Four key trends reshaping strategic M&A in biopharma. This and more in this week’s life sciences industry update. … READ MORE >

Three technologies shaping biotech in 2026. This and more in this week’s life sciences update. … READ MORE >

Biotech capital fundraising is off to a hot start in 2026. This and more in this week’s life sciences update. … READ MORE >

The FDA receives mixed feedback on AI performance monitoring. This and more in this week’s life sciences update. … READ MORE >

Each week we highlight five things affecting the life sciences industry. Here’s the latest. … READ MORE >